Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
NCT ID: NCT00041626
Last Updated: 2007-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
INGN 201
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Introgen Therapeutics
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerstin Menander, MD
Role: STUDY_DIRECTOR
Julie L Sicam, MT (ASCP) MSHS
Role: STUDY_CHAIR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas
Little Rock, Arkansas, United States
Unversity of Colorado Cancer Center
Aurora, Colorado, United States
University of Miami Hospital and Sylvester Comprehensive Cancer Center
Miami, Florida, United States
Norton Healthcare Pavilion
Louisville, Kentucky, United States
Center Center of GBMC
Baltimore, Maryland, United States
WJB Dorn VA Medical Center
Columbia, South Carolina, United States
Mary Crowley Medical Research Center
Dallas, Texas, United States
University of Texas, MD Andersen Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T302
Identifier Type: -
Identifier Source: org_study_id
NCT00040716
Identifier Type: -
Identifier Source: nct_alias